de Jong NWM, Ramyar KX, Guerra FE, Nijland R, Fevre C, Voyich JM, McCarthy AJ, Garcia BL, van Kessel KPM, van Strijp JAG, Geisbrecht BV, Haas PJ. “Immune evasion by a staphylococcal inhibitor of myeloperoxidase”. Proc Natl Acad Sci USA. 2017 Aug 14. pii: 201707032 (https://www.ncbi.nlm.nih.gov/pubmed/28808028)

Fevre C, Scheepmaker L, Haas PJ. “Identifying Bacterial Immune Evasion Proteins Using Phage Display”. Methods Mol Biol. 2017;1535:43-61 (https://www.ncbi.nlm.nih.gov/pubmed/27914072)

Braem SG, Rooijakkers SH, van Kessel KP, de Cock H, Wösten HA, van Strijp JA, Haas PJ. Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation. Journal of Innate Immunity. 2015 Feb 10. (http://www.ncbi.nlm.nih.gov/pubmed/25676601)

Fevre C, Bestebroer J, Mebius MM, de Haas CJ, van Strijp JA, Fitzgerald JR, Haas PJ. Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display. Cellular Microbiology. 2014 Nov;16(11):1646-65. (http://www.ncbi.nlm.nih.gov/pubmed/24840181)

Gustafsson E, Rosén A, Barchan K, van Kessel KP, Haraldsson K, Lindman S, Forsberg C, Ljung L, Bryder K, Walse B, Haas PJ, van Strijp JA, Furebring C. Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies. Protein Eng Des Sel. 2010 Feb;23(2):91-101. (http://www.ncbi.nlm.nih.gov/pubmed/19959567)

Prat C, Haas PJ, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. Journal of Immunology. 2009 Nov 15;183(10):6569-78. (http://www.ncbi.nlm.nih.gov/pubmed/19846866)

Gustafsson E, Haas PJ, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JA, van Kessel KP. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunololgy. 2009 Mar 11;10:13. (http://www.ncbi.nlm.nih.gov/pubmed/19284584)

Haas PJ, van Strijp J. Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res. 2007;37(3):161-75. (http://www.ncbi.nlm.nih.gov/pubmed/17873401)

Haas PJ, de Haas CJ, Poppelier MJ, van Kessel KP, van Strijp JA, Dijkstra K, Scheek RM, Fan H, Kruijtzer JA, Liskamp RM, Kemmink J. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. Journal of Molecular Biology. 2005 Nov 4;353(4):859-72. (http://www.ncbi.nlm.nih.gov/pubmed/16213522)

Haas PJ, de Haas CJ, Kleibeuker W, Poppelier MJ, van Kessel KP, Kruijtzer JA, Liskamp RM, van Strijp JA. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. Journal of Immunology. 2004 Nov 1;173(9):5704-11. (http://www.ncbi.nlm.nih.gov/pubmed/15494522)

de Haas CJ, Haas PJ, van Kessel KP, van Strijp JA. Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology. Biochem Biophys Res Commun. 1998 Nov 18;252(2):492-6. (http://www.ncbi.nlm.nih.gov/pubmed/9826558)